September 19, 2023
Deepcell Expands Commercial Capabilities Hiring Mark Aitkenhead, Ph.D., as Chief Commercial Officer MENLO PARK, Calif. – Deepcell, a pioneer in artificial intelligence (AI)-powered single-cell analysis to fuel deep biological discoveries, today announced the appointment of Mark Aitkenhead, Ph.D., to the newly created position of Chief Commercial Officer. “We are delighted to welcome Dr. Aitkenhead to our [...]
Dual-cap sample collection tube for genetic testing workflows
September 19, 2023
Azenta Life Sciences has launched Cap2TM - a new 0.2ml PCR microcentrifuge tube featuring a novel dual-cap design with both hinged lid and screw cap to preserve the integrity of samples used in genetic testing workflows. Acting as both a collection and processing tube, sample transfer can be minimized making for greater efficiency and less wastage. Designed to ensure [...]
ChromaTan™ Appoints Dr. Rajiv Datar as New CEO
September 19, 2023
An innovative biotools company puts an experienced bioentrepreneur at the helm LOWER GWYNEDD, Pa. -- ChromaTanTM announced today that Dr. Rajiv Datar has been appointed the new President & CEO of the company. A bioentrepreneur with over 25 years C-level experience in bioprocessing and drug development, Dr. Datar succeeds Oleg Shinkazh, the Founder of ChromaTan, who [...]
NanoString Comments on Unified Patent Court Order
September 19, 2023
NanoString Will Immediately Appeal Preliminary Injunction Temporarily Blocking NanoString’s Ability to Market and Sell CosMx Spatial Molecular Imager Products for RNA Detection within UPC Member Countries in Europe SEATTLE -- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, commented on today’s order from the European Unified [...]
September 19, 2023
Agilent Technologies Inc. (NYSE: A) recently signed a Research Collaboration Agreement (RCA) with the National Cancer Centre Singapore (NCCS) outlining their collaboration to accelerate translational cancer research on the genomic landscape of Asian-prevalent cancers over the next two years. The scope of the agreement includes the supply of an Agilent Magnis Next-Generation Sequencing (NGS) Preparation System to [...]
September 19, 2023
Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test SALT LAKE CITY -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to [...]
Akoya Biosciences Sets a New Standard for Scaling Spatial Biology with the Launch of 2.0 Platforms
September 19, 2023
PhenoCycler-Fusion 2.0 enhancements enable the highest throughput workflow for spatial discovery studies. PhenoImager HT 2.0 delivers a 5x greater speed improvement for spatial studies in translational and clinical research. MARLBOROUGH, Mass. -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today highlighted the industry-leading scale and speed in whole-slide, spatial biology workflows enabled [...]
September 19, 2023
Native instrument connectivity, open industry data standards, and built-in scientific metadata are key to unlocking instrument data at scale in Benchling Connect SAN FRANCISCO — Benchling unveiled its new platform for lab instrument connectivity and data management, Benchling Connect, today at Benchtalk, the company’s annual customer event. With Benchling Connect, R&D organizations automate time-consuming, manual lab [...]
September 19, 2023
LONDON and MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) and Cizzle Biotechnology Holdings plc, the UK-based diagnostics developer, are pleased to announce recent progress evaluating specific monoclonal antibodies for Cizzle's CIZ1B cancer biomarker. Cizzle has successfully completed an evaluation programme aimed at assessing the feasibility of using the Simple Western platform from ProteinSimple (a Bio-Techne Brand) for high [...]
Julie Gerardi Joins Parse Biosciences as Vice President of Business Development
September 19, 2023
Veteran biotech executive to head commercial partnerships to accelerate drug discovery SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that Julie Gerardi has joined the company as vice president of business development. Gerardi will lead commercial strategy for large scale applications of Parse’s Evercode Whole Transcriptome, Evercode [...]

